Advanced Search

 

Study ID Status Title Patient Level Data
201351 Completed A Randomized, Placebo Controlled, Repeat Dose, Double Blind (sponsor unblind) Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered with Metformin to Type 2 Diabetes Patients Study Listed on ClinicalStudyDataRequest.com
201357 Active, Not Recruiting Health care resource use and costs associated with use of mepolizumab versus placebo in a clinical trial setting
201358 Active, Not Recruiting Systematic Literature Review and Meta-Analysis of Side Effects of Treatments Used in Advanced Soft Tissue Sarcoma
201362 Completed Administrative database study describing the prevalence of CVD in COPD patients, its impact on exacerbations and health care utilization.
201363 Completed Treatment Pathways in an Inception Lupus Cohort in Atlantic Canada
201364 Active, not recruiting Active Lupus in Canada
201365 Recruiting Special Drug Use Investigation of LAMICTAL Tablets in Patients with Epilepsy (Investigation on Switching to Monotherapy)
201367 Completed Meta-Analysis Plan for 201367, Additional Analysis of Two Multicenter Trials Comparing the Efficacy and Safety of GSK573719/GW642444 with GSK573719, GW642444 and Tiotropium over 24 weeks in Subjects with COPD
201373 Completed Characterization of patients with Chronic Lymphocytic Leukemia in British Columbia, Canada using a province-wide CLL database
201378 Completed A randomized, double-blind, double-dummy, parallel group, multicenter study of once daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, twice daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and twice daily Fluticasone Propionate 250 mcg Inhalation Powder in the treatment of persistent asthma in adults and adolescents already adequately controlled on twice-daily inhaled corticosteroid and long-acting beta2 agonist
201379 Active, Not Recruiting Patterns of Care for Patients with Metastatic Renal Cell Carcinoma in a United States Population
201390 Active, Not Recruiting Impact of Disease Activity on Mortality and Damage Progression in Systemic Lupus Erythematosus (SLE) Patients with Active Disease despite Standard of Care in the Toronto Lupus Cohort
201393 Completed PGx7572: An Exploratory Investigation of CYP2D6 Activity and Efficacy of tafenoquine and primaquine in TAF112582 Part 1
201398 Completed An Exploratory Meta-Analysis of the Efficacy of Dolutegravir across Subgroups
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on ClinicalStudyDataRequest.com
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201435 Completed A randomised, multi-centre, open label, cross-over non-inferiority study to evaluate efficacy, safety and tolerability of Neumoterol 400 and Symbicort Forte in adults with asthma
201450 Not yet recruiting ENCRUSE ELLIPTA Drug Use Investigation
201463 Completed Measurement of neutrophil retention in the lung in vivo, using autologous labelled neutrophils, in healthy subjects following lipopolysaccharide or saline challenge and patients with chronic obstructive pulmonary disease (COPD)
201465 Completed A Phase I Trial to Evaluate Safety and Efficacy of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
201477 Completed Duration of Protection Following Five Doses of GlaxoSmithKline’s (GSK’s) DTaP Vaccines in School Age Children
201479 Completed A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects with Hepatic Impairment and Healthy Matched Control Subjects
201486 Completed PGX6475: PGx evaluation of HLA alleles with rash in lapatinib treated patients from TEACH (EGF105485)
201490 Completed PGx7591: Pharmacogenetic Evaluation of HLA effect on safety events in systemic lupus erythematosus patients treated with GSK2586184 in study JAK115919

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.